FDA Inspection
LabCorp Early Development Laboratories Limited.LabCorp Early Development Laboratories Limited. – FDA Inspection, Sep 27, 2019
Record Details
This FDA Inspection record concerns LabCorp Early Development Laboratories Limited., with an inspection on September 27, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 27, 2019
- Product Type
- Drugs
- Person
- Amanda Lewin (Issuing Officer)
View Company Profile
ID · ab162380-ea21-4607-b002-b89eeee30d60
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1110897
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of LabCorp Early Development Laboratories Limited.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| March 9, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2017 | Not classified | Office of Inspections and Investigations | |
| June 15, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2017 | Not classified | Office of Inspections and Investigations | |
| July 14, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LabCorp Early Development Laboratories Limited.
- FDA Inspection 1181799 - 2022-03-09
- FDA Inspection 1040408 - 2017-12-14
- FDA Inspection 1062207 - 2017-06-15
- FDA Inspection 1011012 - 2017-03-24
- FDA Inspection 893014 - 2014-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.